Summary. To evaluate the role of glucagon on its hepatocyte receptor concentrations, groups of rats were injected with a long-acting glucagon preparation (20 [G-20], 40 [G-40] or 60 [G-60] bLg/100 g body weight) every 8 h for 4 days. Glucagon receptors in liver plasma membranes of treated animals were decreased in number (control = 1.66 + 0.20 ng/0.5 mg protein versus G-20 = 1.24 + 0.26, G-40 = 1.03 _+ 0.26, G-60 = 0.70 + 0.03 ng/0.5 mgprotein;p < 0.05, < 0.001, < 0.001, respectively), but they were indistinguishable from receptors of control rats by other criteria including affinity and kinetics of association. Degradation of both glucagon and receptor sites did not account for differences observed in binding. Similar results were obtained with isolated hepatocytes. In relation to controls, isolated hepatocytes of treated rats had a reduced number of receptors (control = 0.70 _+ 0.05 versus G-40 = 0.47 _+ 0.04 ng/106 cells; p < 0.02) proportionate to the decreased glucagon-stimulated production of cyclic AMP and glucose. Four to eight hours exposure of cultured hepatocytes of nontreated rats to 4 x 10 -8 tool/1 glucagon produced a decreased binding of 125I-glucagon to its receptor (p < 0.05). In contrast, hormone exposure for shorter periods of time (0-2 h) was without effect. These results suggest (1) an inverse relationship between circulating glucagon levels and hepatocyte glucagon receptor concentration, and (2) a direct relation between receptor number and target-cell response.
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Hormones may modify their own receptor number. This phenomenon, first described for insulin [1] , has subsequently been shown for several other hormones [2-41. In relation to glucagon, there is contradictory evidence concerning the role of this hormone in the regulation of its own receptors. Hyperglucagonaemia of fasted [5] and developing rats [6] , and animals undergoing liver regeneration [7] is associated with a decrease of binding sites for glucagon in the liver. There is also a proportional reduction of glucagon-stimulated adenylate cyclase activity, whereas in the hyperglucagonaemic state observed in chronic renal failure of liver glucagon receptors are increased [8] . There is contradictory evidence concerning high circulating levels of glucagon found in diabetic animals; both increased [9] and decreased [10] binding of glucagon to liver membranes has been described. After the parenteral administration of exogenous glucagon, a decrease in the number of liver receptors for glucagon has been reported [10] [11] [12] , but again it is not clear whether this modification is accompanied [10, 11] or not, by changes [t2] in the glucagon-stimulated adenylate cyclase activities.
In view of the contradictory reports, an experimental model has been developed which would firstly permit the correlation of the effects of glucagon on (a) its receptor concentrations in the liver and (b) the relationship between glucagon receptor number and target-cell response and secondly elucidate whether the action of glucagon on its own receptors is due to a direct effect.
Materials and Methods

Experimental Animals
Male Wistar rats, weighing 120-150 g, were housed under constant conditions of lighting and temperature. Animals were fed on a standard diet (fat 3.8%, carbohydrates 49.5%, protein 21.4%). The experimental groups of rats included: (1) three groups injected subcutaneously with different doses (60 ug, 40 ~tg or 20 ~tg/100 g body 0012-~86X/82/0022/0362/$02.00 weight) of long-acting glucagon (protamine-zinc-glucagon, Novo lndustrias, Copenhagen), every 8 h (administered at 0800, 1600 h and midnight) for a period of 4 days, and (2) a control group of rats which were injected subcutaneously with placebo (protaminezinc).
Measurement of Immunoreactive Glucagon
Overnight fasted control and glucagon-treated rats were anaesthetized with ether and blood samples were taken from the portal vein. The blood samples were collected in pre-chilled test tubes containing apronitin (Trasylol, FBA Pharmaceuticals, New York, 500 KIU/ml) and EDTA (1.2 mg/ml), centrifuged at 4~ and the plasma was preserved frozen until analyzed. Blood plasma glucagon was determined by radioimmunoassay [13] with a C-terminal reactive antiglucagon serum (30K) (generously donated by Dr. R. H. Unger, Dallas). Sensitivity of the assay was up to and including 20 pg/ml and the percentage of intra-and inter-assay variation was 3 and 6% respectively.
Preparation of Liver Plasma Membranes
Livers from rats fasted overnight were taken immediately after post mortem. After removal, the livers were quickly minced and homogenized in I mmol/l NaHCO3 solution (10 g in 500 ml of 1 mmol/1 NaHCO3) at 4 ~ C. Partially purified liver plasma membranes were prepared by the method of Neville [14] as modified by Pohl et al. [15] and stored in liquid nitrogen. To provide an index of membrane purification, binding of 125I-glucagon to its liver receptors and 5'nucleotidase activity [16] were determined in the whole liver homogenate, the 1500 g pellet and the partially purified liver membranes. Membrane protein was determined by the method of Lowry et al. [17] .
Isolation of Hepatocytes
Isolated hepatocytes were prepared from normal and glucagontreated rats fasted overnight. The animals were anaesthetized with ether, the abdomen opened through a wide incision and the portal vein exposed and cannulated. The liver was then perfused with 120 ml of calcium and magnesium-free Krebs Ringer bicarbonate buffer (pH 7.4) for 4 min. Another 150 ml of perfusion medium with 40 mg of collagenase type I (160 units/mg; Sigma Chemicals, St. Louis, USA) were infused into the liver for 5 rain. Atthe end of the perfusion period, the liver was removed, cut into fine pieces and incubated with Krebs Ringer bicarbonate buffer (pH 7.4) and 10 g/1 bovine serum albumin at 37 ~ C with slow stirring for 5 min. The digested liver was filtered and the cells spun down at 50 g for 2 min. All procedures with isolated cells and liver membranes were carried out in plastic laboratory ware. Cell number was determined by counting in a Neubauer chamber. Cell size was measured after determining the cell diameter of hepatocytes (at least 50 cells were evaluated in each cell suspension) visualized with a phase contrast microscope.
Tests of Hepatocyte Viability
Biochemical and morphological approaches were used in order to test cell Viability. Trypan blue exclusion was determined by the ability of hepatocytes to exclude 0.5% (w/v) of the stain in the absence of albumin for 2 rain. Ultrastructure of the isolated hepatocytes was studied with the electron microscope [18] . The adenosine triphosphate (ATP) content of the cells was determined by the method of Williamson and Corkey [19] .
Binding of glucagon to their hepatocyte receptors and cyclic AMP production in the absence or presence of different glucagon concentrations were also determined. The rate of gluconeogenesis was measured by assaying the glucose content in the incubation buffer immediately after the cell suspension was added and at different times thereafter (0-2 h).
Iodination of Glucagon and Insulin
Mono-125I-glucagon was obtained according to the procedure of Nottey and Rosselin [20] with specific activities of 450-500 .uCi/gg. Iodination was carried out in at a total volume of 100 gl of 0.3 tool/1 phosphate buffer (pH 7.4) containing 5 gg porcine glucagon (Novo Industrias, Copenhagen), 2.5 mCi of 125I-Na and chloramine-T (25 ug) for 30 s. This was immediately followed by the addition of sodium metabisulphite (50 ag) and 100 .ul of 0.3 mol/l phosphate buffer (pH 7.4) with 10 g/1 bovine serum albumin. Trichloroacetic acid precipitability or talc adsorption of the iodinated hormone was 80% -90%. The reaction mixture was applied to a 0.9 x 30 cm DEAE cellulose column (Whatman 52) equilibrated with 0.05 tool/1 Tris-HCl and 7 mol/1 urea (pH 9.3) at 4~ After the passage of 80 ml of the same buffer, a linear gradient of NaC1 from 0 to 0.2 mol/l was run. Mono-iodinated hormone obtained after column chromatography was dialyzed against 0.3 mol/1 phosphate buffer (pH 7.5) and immediately stored at -20 ~ C. With a similar procedure, porcine insulin monocomponent (Novo Research Institute, Denmark) was iodinated with Na125I (Radiochemical Centre, Amersham, Bucks, UK) to yield specific activities of 240-300 laCi/ .ug. Mono-125-I-insulin was obtained after the iodinated mixture was chromatographied on DEAE cellulose column (0.9 x 30 cm, Whatman 52) with 0.05 mol/l Tris-HC1 (pH 9.3) and a linear gradient of NaCI (0-0.1 mol/l).
Measurement of Hormone Binding to Liver Membranes and Isolated Hepatocytes
The binding to liver membranes of mono-iodinated hormone was carried out as described by Rubalcava and Rodbell [21] . Liver membranes (100-200 p~g of protein/ml) were incubated with Krebs Ringer phosphate buffer (pH 7.5) (NaCI: 118 mmol/1, KCI: 5 mmol/1, MgSO4:1.2 mmol/l, KH2PO4:1.2 mmol/l, Na2HPO4: 10 mmol/I, 10 g/1 bovine serum albumin and mono I~5I-glucagon (5 x 10 -11 tool/l)) at 10 ~ C or 20 ~ C for 0-9 h, unless otherwise indicated. At the end of the incubation periods, the samples were diluted out rapidly in Krebs Ringer phosphate buffer (pH 7.5) with 1 ml of ice-chilled solution of 10 g/1 albumin and immediately filtered on oxoid filters (0.45 gm) soaked in 100 g/1 albumin for 30 min before use. To correct for non-specific adsorption of the peptides to liver membranes, the binding of radioactive hormone was determined in the presence of 1 x 10 -6 mol/1 unlabelled glucagon, a concentration which would more than saturate specific hormone-binding sites. The difference between membrane-bound radioactivity in the absence or presence of an excess of unlabelled hormone was considered to represent binding of labelled hormone to specific binding sites. Radioactivity was determined in a welltype scintillation counter. The same experimental procedure was followed in the binding studies with isolated hepatocytes except that Krebs Ringer bicarbonate buffer (pH 7.4), was used as the incubation medium.
Hormone degradation was studied after the incubation of J25I-glucagon (1 x 10 -l~ tool/l) with liver membranes (0.I3 mg/ml) or isolated hepatocytes (166 cells/ml) and Krebs Ringer buffer containing albumin (10 g/l) for the indicated times. The supernatant then was removed and the percentage of counts that bound to fresh liver membranes during a subsequent period of incubation was de-termined. Tubes incubated under identical conditions without liver membranes or cells in the first incubation served as controls. The percentage of hormone degraded was calculated, as a function of the control by comparing the percentage of counts of lzSI-glucagon that bound to liver membranes or isolated hepatocytes during the first incubation and after the second one with fresh liver membranes. Glucagon receptor degradation by liver membranes of control and glucagon-treated rats was studied as a function of time and temperature. Liver membranes (0.15 mg/ml) were pre-incubated in tubes containing Krebs Ringer phosphate (pH 7.5) and albumin (10 g/l) at 10~ or 20~ for the indicated times. The tubes were then equilibrated in a 20~ water bath and ~25I-glucagon was added. In a second set, unlabelled glucagon (1 x 10 -6 mol/l) was also added to measure non-specific binding. Incubations were carried out at 20 ~ C for 90 rain. The specific ~25I-glucagon binding was expressed as a percentage of the binding observed with no pre-incubation.
Glucagon-Stimulated Glucose and Cyclic AMP Production by Rat Hepatocytes
Isolated hepatocytes (2 x 106 cells/ml) were incubated with Krebs Ringer bicarbonate (pH 7.4) (NaCI: 120 mmol/1, KC1: 4.8 mmol/1, CaCI: 1.3 mmol/1, KH2PO4:1.2 retool/l, MgSO4:1.2 retool/l, NaHCo3:24 mmol/1) containing 40 g/1 bovine serum albumin (BSA), alanine (10 retool/l) and in the presence (5.5 • 10 -7 mmol/1) or absence of glucagon and cyclic AMP (0.8 mmol/l).
Cell suspensions were gassed with 95% oxygen/5% carbon dioxide, and incubated with gentle shaking at 37 ~ C. The fraction V bovine albumin powder was defatted before use by the procedure of Guillory and Racker [22] . At the end of the incubation period, the samples were chilled in an ice bath, centrifuged and aliquots of the medium taken for glucose assay by the glucose oxidase method [231.
In those experiments in which cyclic AMP production by hepatocytes was studied, the incubation medium was supplemented with 2 mmol/l theophylline, and glucagon was added in a broad concentration range from 0 to 10 -6 mol/1. Cyclic AMP accumulation was increased by glucagon with a maximal effect at 2.5 min, the values decreasing almost to basal levels by 20 min. At 60 and 120 min of incubation, cyclic AMP values were indistinguishable from basal concentrations. Therefore, 2.5 min incubation periods were selected to study the glucagon-stimulated cyclic AMP production. After 2.5 min of incubation, cell suspensions were treated with trichloacetic acid (5% final concentration, w/v), centrifuged and the supernatant washed with ether saturated with water. In aliquots of the aqueous phase, cyclic AMP was assayed by radioimmunoassay as described by Steiner et al. [24] . Sensitivity of the assay was up to and including 0.2 pmol and the percentage of intraand inter-assay variation were of 4 and 8%, respectively.
Pre-Incubation of Hepatocytes with Glucagon
Isolated hepatocytes from control rats were incubated at 37 ~ C in a 199 medium (Gibco Bio-Cult) supplemented with 10 g/l bovine serum albumin, penicillin and streptomycin (2000 U and 2 mg/ml, respectively) for 0-8 h in the presence (4 x 10-Smol/l) or absence of glucagon.
Washing Procedure Before l:5 I-Glucagon Binding
After pre-incubation, aliquots of cell suspensions were transfered to plastic centrifuge tubes containing 2 ml of Krebs Ringer bicarbonate and spun at 50 g for 2 min. Cells were immediately resuspended in 3 ml of Krebs Ringer bicarbonate, BSA 10 g/l and incubated at 37 ~ for 30 rain. This incubation time was expected to be long enough to dissociate all the glucagon molecules bound to receptors during the pre-incubation period. In order to demonstrate this, aliquots of hepatocytes previously incubated without glucagon, were incubated at 37~ for 10 rain with glucagon (1 • 10 -7 tool/l), and it was found, using the above procedure that the hormone dissociates immediately afterwards. No differences in ~25I-glucagon binding to cells previously incubated with or without glucagon (1 x 10 -v tool/l) were found.
l:5 I-Glucagon Binding to Washed Cells
For binding studies, 125I-glucagon was incubated with washed cells (5 x 105) in a total volume of 0.5 ml at 20 ~ in the presence or absence of 10-6 tool/1 glucagon. After 20 rain of incubation, the cells were separated from the assay buffer by microfiltration. The radioactivity bound to cells in the presence of 1 x 10 -6 mol/l glucagon was considered non-specific binding and was subtracted from total binding.
Statistical Analysis
Results have been expressed as mean _+ SEM. For statistical comparisons Student's t-test was used.
Results
In control rats the blood plasma glucagon levels in the portal vein (control = 360 + 63 pg/ml; n = 10) were significantly smaller (p < 0.01) than those found in rats treated with 20, 40 or 60 lxg of protamine-zincglucagon/100 g body weight per 8 h during 4 days (G-20 = 850 + 160; G-40 = 1200 + 400; G-60 = 2,800 ___ 515 pg/ml; n = 10). Glucagon levels in the portal vein of glucagon-treated rats were within the range obtained in non-treated animals after a physiological stimulus.
No statistically significant differences of 5'nucleotidase activity and protein yield at the different stages of the purification procedure of liver plasma membranes were found between control and glucagon-treated rats. Thus, the total protein content in liver homogenates, was control = 2 011 + 72, G-20 = 2200 _+ 115, G-40 = + 2040 _+ 115 and G-60 --1947 + 107 mg/10 g wet tissue. A similar protein content was obtained in the partially purified liver membranes of control (14 ___ 2 mg) and of rats pre-treated with 20 pog (10 _+ 11 rag) 40 lxg (12 ___ 1 mg) and 60 ~tg Time (h) Fig. 1 . Time course of association of glucagon liver membranes. 125I-glucagon was incubated with liver membranes from control (0.12 mg/ ml) and glucagon-treated rats (0.10 mg/ml) at 10 ~ or 20 ~ C. The specific 125I-glucagon binding was determined and plotted as the percentage of maximal 125I-glucagon binding. The single solid line approximates the time course for both control ( 9 9 and glucagon-treated rats (40 p~g/100 g body weight per 8 h) ( 9 9 The points are the mean of data obtained with liver membranes of three different rats. Percentage of variation interassay ranges from 2.5 to 10 Results expressed as mean _+ SEM (n = 10) ND: not detected a See Methods for definition of purification fractions 9.4, 9.1 and 8 in the control, G-20, G-40 and G-60 groups, respectively. Hovever, at every step in the purification, there was less glucagon binding (Table 1) by the liver fraction of glucagon treated rats. Binding decreased progressively with increasing pre-treatment dose of protamine-zinc-glucagon.
To assess the kinetic properties of the glucagon receptors of the liver membranes from control and glucagon-treated rats (40 ug/100 g body weight per 8 h), association of the ~25-I-glucagon with both types of membranes were compared at 20~ and 10~ (Fig. 1) . When maximal binding of t2LI-glucagon to both kinds of membranes was normalized, the time courses of association were similar. Maximum binding occurred at 4 h both at 10 ~ C and at 20 ~ C. Direct measurement of glucagon degradation suggested that it is a very rapid process, which is dependent on temperature (10 ~ and 20 ~ C) and incubation time (0-7 h). However, the same degradation rate of glucagon by liver membranes of control and glucagon pre-treated rats (40 ~g of protamine-zincglucagon/100 g body weight per 8 h) was observed (p > 0.05). The increase in degradation of the receptor was a function of temperature (10 ~ and 20~ and time of incubation (0-7 h) and no differences were O/100g body weight per 8 h). Liver membranes (0.15 mg/ml) were incubated with Krebs Ringer phosphate (pH 7.5) containing albumin (10 g/ 1), 125I-glucagon (0.28 ng/ml) and in the absence or presence 9 labelled glucagon (from 0.3 to 1000 ng/ml) at 20~ for 4 h. Each point represents the mean of data obtained with liver membranes of five different rats found between both groups of liver membranes (p > 0.05).
When the percentage of ~25I-insulin bound to liver membranes (at 20 ~ C 4 h incubation) of control and glucagon-treated rats (40 ~tg/100 g body weight per 8 h) was plotted as a function of insulin concentration (from 0.3 to 1000 ng/ml), there was no difference in the two groups in binding of insulin to liver membranes (2 > 0.05).
Hepatocytes were isolated from livers of control and glucagon-treated rats (40 ~tg protamine-zinc-glucagon/100 g body weight per 8 h). The cell suspension was predominantly free hepatocytes, which were 80% viable as judged by their ability to exclude 5 g/1 trypan blue in the absence of albumin for 2 min. These Time (min) Fig. 3 . Time course of association of glucagon to isolated hepatocytes. 125I-glucagon (0.9 x 10-~0 mol/l) was incubated with isolated hepatocytes (1 • 106 cells/ml) in Krebs Ringer bicarbonate (pH 7.4), containing 10 g/1 albumin for the times and the temperatures indicated ( 9 9 control rats; ( 9 0) glucagon-treated rats (40 ~tg/100 g body weight per 8 h). Each value represents the mean of the data obtained with hepatocytes of five different rats. Percentage of variation interassay ranges from 3 to 9 cells were shown to be metabolically active and sensitive to glucagon. Their structures were also very well preserved as observed by electron microscopy. The liver cells obtained from both experimental groups consisted of about 90% hepatocytes. Mean cell diameter was almost the same in overnight fasted control (24 + 0.1 ~tm; n = 6) and glucagon-treated (23.4 _+ 0.1 ~tm; n = 6) rats. The isolated hepatocytes retained their ability to bind glucagon, increase the rate of gluconeogenesis from alanine over 2 h incubation period and augment the production of cyclic AMP proportionately to the amount of glucagon added to the incubation medium. The ATP content of these cells was 12.4+0.4 nmol/mg protein (39.3 4--0.8 nmol/106 cells). These results are similar to those reported by others [25] .
As shown in Figure 3 , maximum binding of 125I-glucagon to isolated hepatocytes was obtained with 10 min of incubation at 30~ compared with at 30 min at 20 ~ C. The time courses of association of 12SI-glucagon to both kinds of hepatocytes when normalized to the maximal binding were indistinguishable up to 30 min at 20 ~ C or 10 rain at 30 ~ C. After the maximal binding was reached, the specific binding of I25I-glucagon began to decrease.
In contrast with the results obtained with liver membranes, the dissociation of ~25-I-glucagon from isolated hepatocytes (Fig. 4) was significantly accelerated by dilution of the incubation mixture or by the addition of unlabelled glucagon.
When the percentage of 12SI-glucagon that was bound by the cells was plotted as a function of glucagon concentration (Fig. 5) , a decrease in the glucagon As shown in Figure 6 the degradation of 125I-glucagon by the hepatocytes of control and glucagontreated rats, when incubated at 10 ~ and 20 o C, was similar during the 90 min of incubation (p > 0.05), with all values higher at 20 ~ C.
As shown in Figure 7 , the stimulation of cyclic AMP production by glucagon in both populations of hepatocytes was a function of hormone concentrations. In addition, the concentrations ofglucagon giving half-maximal (2 x 10 -9 mol/1) or maximal (10 -7 tool/l) effects were the same in both groups. However, smaller responses were obtained with the hepatocytes from glucagon-treated rats (control versus G-40 at 10 -1~ and 5 x 10 -l~ mol/1 of glucagon, p < 0.05; at 10 -8 and 10-7 mol/l, p < 0.02 and at 10 -9 mol/1, p < 0.01). Isolated hepatocytes ofglucagon-treated rats had a proportionate reduction (33%43%) of glucagon-stimulated production of cyclic AMP and of the number of glucagon receptors. Under basal conditions, glucose production by the hepatocytes of control and glucagon treated rats was similar at any time of incubation (p > 0.05, Table 2 ). Nevertheless, in the presence of glucagon (5.5 x 10 -7 mol/1), the glucose release by hepatocytes of glucagon pre-treated rats was significantly decreased compared with glucose release by cells of control animals (controls versus G-40 at 60 min, p < Time (rain) Fig.6 . Degradation of glucagon by isolated hepatocytes. 125I-glucagon (1 x 10 -1~ mol/l) was incubated with I~'ebs Ringer bicarbonate (pH 7.4), containing albumin (10 g/l) and hepatocytes (106 cells/ml) of control (Q S) and glucagon-treated rats (40 p~g/]00 g body weight per 8 h). ( 9 9 for the times indicated at 10 ~ C or 20 ~ C. The supernatant was then removed and the percentage of counts that bound to liver membranes during a subsequent incubation at 20 ~ C for 90 min was determined. Vials incubated under identical conditions without cells in the first incubation served as controls. The percentage of hormone degraded was calculated, as a function of the controls, by comparing the percentage of counts of 125I-glucagon that bound to isolated hepatocytes during the first incubation and after the second incubation with liver membranes. Each value represents the mean of the data obtained with hepatocytes of three differents rats. Percentage of variation interassay ranges from 1 to 5 0.05; at 90 min, p < 0.05; at 120 min, p < 0.025). In addition, the differences between glucagon-stimulated and basal glucose production by hepatocytes of control rats were statistically significant at 60 min (p < 0.05), 90 min (p < 0.05) and 120 min (p < 0.025), but no statistically significant differences were observed when the hepatocytes of rats pre-treated with glucagon were incubated in the absence or presence of the hormone (p > 0.05). However when cyclic AMP (0.8 mmol/1) was added to the incubation medium, the glucose production increased to the same or even greater concentrations than that observed in non-treated animals (Table 3) .
When the hepatocytes of control rats were pre-incubated in the absence of glucagon (Table 4) , the binding of 125I-glucagon to these cells increased markedly in relation to the initial binding. Conversely, pre-incubation of hepatocytes during 4 h with glucagon (4 x 10 -8 mol/1) produced a decrease (30%) in the binding of 125I-glucagon to these cells, which was more marked (39%43%) after 6 h (p < 0.05) or 8 h (p < 0.05) of pre-incubation. Acute exposure of hepatocytes to glucagon (2 h) was without effect (p > 0.05).
Discussion
Receptor regulation occurs in many human and animal tissues and is important for the biological activity of hormones as it serves to regulate target cell sensitiv- at present there is contradictory evidence about a glucagon-dependent regulation of these receptors. Since most of these studies were carried out in vivo and, under these circumstances, both endogenously and exogenously-induced hyperglucagonaemia are associated with marked changes of other hormones or metabolites, clear-cut evidence of a direct hormonal effect could not be obtained. In an attempt to elucidate the role of glucagon on its hepatic receptors, we have designed a model in which both exposure in vivo and in vitro to the hormone were achieved. A persistent hyperglucagonaemia in vivo was induced by injecting repeatedly a long-acting glucagon preparation, avoiding the undesirable rebound effects provoked by the administration of soluble crystalline glucagon. The amount of glucagon injected was adjusted in such a manner that the resulting glucagon concentrations in plasma were close to the physiological level. The recovery of plasma liver membrane protein and marker enzyme activities indicate that there were no significant differences in the membrane purification procedure followed with the groups of rats that comprise the present study. Decreased 125I-glucagon binding to liver membranes of glucagon-treated rats reflects a decrease in the number of glucagon receptors. Comparison of the Scatchard curves at the same degree of fractional saturation indicates that the apparent affinities were the same, with the major alteration being the decrease in receptor concentration. However, 125I-insulin binding to liver membranes of control and glucagon-treated rats was the same, suggesting a specific role for glucagon. Studies of the kinetic properties of the glucagon receptor of control and glucagon-treated rats revealed that association rates were indistinguishable. Furthermore, the degradation of glucagon and glucagon receptors was identical in glucagon-treated and control groups of rats, suggesting that the observed changes in glucagon binding do not appear to be related to alterations in glucagon degradation by the liver membranes or by a different stability of the receptor during the incubation periods.
The interactions between glucagon and its receptor were studied in isolated hepatocytes in an attempt to eliminate possible changes in receptor properties and in the composition of plasma cell fractions originating during the isolation procedure [26] . By these experiments we established that qualitative and quantitative properties of glucagon-receptor interactions of both experimental groups of rats were identical from isolated hepatocytes and plasma liver membranes.
Since alterations in hormone binding and hormone action are not always parallel, comprehensive analysis of the binding data in isolated hepatocytes can be gained with simultaneous measurement of the biological response to glucagon. This analysis is important since the glucagon receptor population may be heterogenous [27] and also because some binding sites may not necessarily lead to an ultimate biological response. Thus, Birnbaumer and Pohl [28] have reported that binding to only 20% of glucagon receptors is sufficient to obtain a maximal hormonal response. However, the results reported in this study indicate that the reduced number of glucagon receptors in hepatocytes from glucagon-treated rats was proportional to the diminished cyclic AMP and glucose production induced by this hormone.
From the data obtained both with liver membranes and isolated hepatocytes, we can assume that the reduced response to glucagon by the cells of rats treated with this hormone is fully accounted for by the decreased concentrations of the glucagon receptors which are otherwise normal according to the functional criteria discussed above.
This statement was reinforced by the fact that hepatocytes of control rats, when cultured in the presence of glucagon, showed a loss of binding sites for this hormone, indicating a direct effect ofglucagon in their receptor concentrations. The decrease of binding sites for glucagon cannot be accounted for by a contamination of the receptor with the glucagon added during the pre-incubation period, since this effect was not observed during the first 2 h of treatment with glucagon 4 x 10 -8 mol/1. Furthermore, the hormone dissociation procedure followed, and the subsequent washing of the hepatocytes proved to be good enough for removing unlabelled glucagon from these cells.
Possible mechanisms involved in the reduction of glucagon receptors by the homologous hormone could be related to: 1) decreased synthesis; 2) modified subunit or storage pools; or 3) activated degradation of the receptor. Thus, the amount of a given membrane protein seems to be a consequence of an equilibrium between synthesis and degradation [29] and these activities can be modified under different physiological situations [30] . As has been reported [4, 31] , down regulation of insulin and growth hormone receptors is related more to an increased degradative rate of their receptors than to a decreased biosynthesis.
Since glucagon has powerful catabolic properties, the existence of a down regulation mechanism could protect target cells from undesirable effects. This seems likely to occur in pathophysiological situations, such as starvation, development and liver regeneration. In fact, all these circumstances have in common hyperglucagonaemia co-existing with a reduced number of glucagon binding sites and decreased activity of glucagon-stimulated adenylate cyclase. The same criteria could be applied to the apparent evanescence of glucagon's biological activity observed in non-diabetic animals [32] and man [33] during the constant infusion of glucagon. However, on the other hand, not every situation of hyperglucagonaemia results in the same fall in glucagon receptor concentrations, probably because other factors or metabolic disturbances can be opposed to the effect of glucagon on their receptors.
